AI-Driven Multi-Channel RF Ablation System

Publication ID: 24-11857245_0010_PTD
Published: November 07, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “AI-Driven Multi-Channel RF Ablation System,” Published Technical Disclosure No. 24-11857245_0010_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857245_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,245.

Summary of the Inventive Concept

A next-generation multi-channel RF ablation system that leverages artificial intelligence, machine learning, and real-time feedback to optimize ablation procedures, ensuring more accurate and effective treatments.

Background and Problem Solved

The original patent for multi-channel RF ablation, while effective, has limitations in terms of manual control signal frequency and amplitude adjustments, which can lead to suboptimal treatment outcomes. The new inventive concept addresses this issue by introducing AI-driven control signal optimization, real-time feedback analysis, and automated error detection, revolutionizing the field of RF ablation.

Detailed Description of the Inventive Concept

The AI-driven multi-channel RF ablation system comprises a neural network that predicts optimal control signal frequencies and amplitudes for each ablation channel, a signal generator that generates the control signals and ablation signals accordingly, and a central controller that synchronizes the signal generators and adjusts the control signal frequencies and amplitudes in real-time based on feedback from the ablation procedure. The system can also utilize a database of pre-calculated optimal control signal frequencies and amplitudes for various ablation procedures and tissue types, and machine learning algorithms to analyze feedback and adapt the control signals for optimal performance. Furthermore, the system includes automatic detection of ablation electrode placement errors using machine learning algorithms to analyze the control signal frequencies and amplitudes and detect anomalies indicative of electrode misplacement.

Novelty and Inventive Step

The new inventive concept introduces a paradigm shift in multi-channel RF ablation by incorporating AI-driven control signal optimization, real-time feedback analysis, and automated error detection, which are not present in the original patent. The use of neural networks, machine learning algorithms, and real-time feedback analysis enables a level of precision and adaptability that was previously unachievable.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different AI architectures, such as deep learning or reinforcement learning, or the integration of additional sensors and feedback mechanisms to further enhance the system's accuracy and adaptability. Variations could also include the application of the AI-driven control signal optimization to other medical procedures beyond RF ablation.

Potential Commercial Applications and Market

The AI-driven multi-channel RF ablation system has significant commercial potential in the medical device industry, particularly in the fields of cardiac electrophysiology and interventional cardiology. The system's ability to optimize ablation procedures and reduce treatment times could lead to increased adoption and market share, as well as improved patient outcomes and reduced healthcare costs.

CPC Classifications

SectionClassGroup
A A61 A61B18/1206
A A61 A61B18/1492
A A61 A61B2018/00351
A A61 A61B2018/00577
A A61 A61B2018/00702
A A61 A61B2018/00732
A A61 A61B2018/00767
A A61 A61B2018/00791
A A61 A61B2018/00827
A A61 A61B2018/00875
A A61 A61B2018/00892
A A61 A61B2018/128
A A61 A61B2018/1273

Original Patent Information

Patent NumberUS 11,857,245
TitleMulti-channel RF ablation
Assignee(s)Biosense Webster (Israel) Ltd.